FDAsafety guidance66% confidence
FDA AP — TRAMADOL HYDROCHLORIDE (SUPPL)
Source: FDA
Why This Matters
Why this matters: sets a safety guidance precedent in the same sub-indication (pain) as Strides Pharma; the same agency is already in play for this signal, so precedent weight is higher.
Regulatory Analysis
Application ANDA075968. Sponsor: GRAVITI PHARMS. Submission status: AP. Submission type: SUPPL. Active ingredients: TRAMADOL HYDROCHLORIDE.
Supporting Context
- Therapeutic area
- Pain Management · Analgesic
- Sub-indication
- Pain
Related signal: FDA Approval Update for Tramadol Hydrochloride Supplement by Strides Pharma